The Food and Drug Administration has approved a new test, the Abbott Prism HIV O Plus assay, that detects HIV antibodies in donated blood and organs.
The test is one of five that run on Abbott’s fully automated Prism System. FDA said the test identifies antibodies to HIV type 1, groups M and O, and to HIV type 2. It is the second donor screening test licensed to detect antibodies to HIV type 1, group O.
Positive results for the test still require confirmatory supplemental testing, officials said.
